Universe Pharmaceuticals (UPC) Long-Term Investments: 2020-2024
Historic Long-Term Investments for Universe Pharmaceuticals (UPC) over the last 5 years, with Sep 2024 value amounting to $712,494.
- Universe Pharmaceuticals' Long-Term Investments rose 3.97% to $712,494 in Q3 2024 from the same period last year, while for Sep 2024 it was $712,494, marking a year-over-year increase of 3.97%. This contributed to the annual value of $712,494 for FY2024, which is 3.97% up from last year.
- Per Universe Pharmaceuticals' latest filing, its Long-Term Investments stood at $712,494 for FY2024, which was up 3.97% from $685,307 recorded in FY2023.
- In the past 5 years, Universe Pharmaceuticals' Long-Term Investments registered a high of $735.0 billion during FY2020, and its lowest value of $685,307 during FY2023.
- In the last 3 years, Universe Pharmaceuticals' Long-Term Investments had a median value of $702,890 in 2022 and averaged $700,230.
- As far as peak fluctuations go, Universe Pharmaceuticals' Long-Term Investments crashed by 100.00% in 2021, and later grew by 3.97% in 2024.
- Over the past 5 years, Universe Pharmaceuticals' Long-Term Investments (MRY) stood at $735.0 billion in 2020, then plummeted by 100.00% to $744,924 in 2021, then fell by 5.64% to $702,890 in 2022, then dropped by 2.50% to $685,307 in 2023, then rose by 3.97% to $712,494 in 2024.
- Its Long-Term Investments stands at $712,494 for FY2024, versus $685,307 for FY2023 and $702,890 for FY2022.